Biosimilars Quick Guide

A doctor talks with a patient over a clipboard.

Today, there are more biosimilars available to manage psoriatic disease than ever before. A biosimilar is a U.S. Food and Drug Administration (FDA) approved biologic product that is very similar to another FDA-approved biologic reference product. Biosimilars are given through injections or intravenous (IV) infusions.

Request your free resource to learn more about:

FDA approval of biosimilars and interchangeable products
Why biosimilars are not called generic versions of a biologic
Biosimilars available to treat psoriasis and psoriatic arthritis
Risks and side effects of biosimilars

(An NPF Patient Navigator will email your resource(s) to you within 1-3 business days.)

First name

Last name

Email address

Street address

City

State

Postal code

Country

We use cookies to offer you a better experience and analyze our site traffic. By continuing to use this website, you consent to the use of cookies in accordance with our Privacy Policy.